Results 1 to 10 of about 5,637,645 (256)

Circulating Tumor Cells in Soft Tissue Sarcoma: Current Evidence and Clinical Implications. [PDF]

Cancers (Basel)
Mendez-Guerra C, Chacon J, Altamirano IE, Calmet Rocca WR, Pretell-Mazzini J.   +4 more
europepmc   +1 more source

Isolation and typing techniques for circulating tumor cells. [PDF]

Biomark Res
Wu S, Rong S, He A, Xia Y, Xu F.
europepmc   +1 more source

Correction to: Circulating Tumor Cells in Early Breast Cancer. [PDF]

JNCI Cancer Spectr
europepmc   +1 more source

Circulating Tumor Cells: Emerging Frontiers in Cancer Technology. [PDF]

Expert Rev Mol Med
Agarwal P, Raman R, Bhagwat M, Agarwal P, Kumar P.   +4 more
europepmc   +1 more source

Combining circulating tumor cells and tumor-derived extracellular vesicles for prognosis stratification in patients with metastatic breast cancer. [PDF]

ESMO Open
Nicolò E, Sandoval JL, Foffano L, Cyrille S, Lei W, Arpino R, Berger F, Munoz-Arcos L, Pontolillo L, Serafini MS, Gianni C, Bayou N, Davis AA, Liu H, Gradishar WJ, Curigliano G, Gerratana L, Zhou XK, Renault S, Cristofanilli M, Bidard FC, Reduzzi C.   +21 more
europepmc   +1 more source

Predictive Value of Circulating Tumor Cells in Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer. [PDF]

Thorac Cancer
Yang J, Qin Z, Zhou Z, Liu J, Chen L, Mo Z, Liao M, Cui D, Wu K, Tang D, Chen J, Chen C.   +11 more
europepmc   +1 more source

Predictive value of Slug-positive circulating tumor cells for neoadjuvant chemotherapy response in mesenchymal malignancies. [PDF]

J Cancer Res Clin Oncol
He N, Liu S, Cui H, Feng J, Liang W, Yao B, Amu F, Xu B, Fan Q, Hao P.   +9 more
europepmc   +1 more source

Dietary fat, inflammation, circulating tumor cells, and circulating tumor DNA in colorectal cancer survivors: An exploratory cross-sectional study. [PDF]

J Acad Nutr Diet
Compton SLE, Cho E, Spielmann G, Yi F, Yang S, Brown JC.   +5 more
europepmc   +1 more source

Clinical applications and future perspectives of circulating tumor cells in solid tumors. [PDF]

Discov Oncol
Hajizadeh A, Momeni F, Eslami NM, Rajeh SM, Parsian A, Birgani RG, Kananpour N, Pourzare P, Aghili A, Samarjan RS, Ghavamikia N, Shayan SK.   +11 more
europepmc   +1 more source

Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab. [PDF]

Cancer Discov
Mishra A, Meador CB, Kikkeri K, Cunneely Q, Lin M, Carmona-LaSalle TJ, Huang SB, Bell R, Putaturo V, Xia W, Liang JH, Fang J, San Vicente S, Zielinski CE, Digumarthy SR, Hung YP, Yeap BY, Edd JF, Lawrence MS, Sade-Feldman M, Sen DR, Toner M, Maheswaran S, Gainor JF, Haber DA.   +24 more
europepmc   +1 more source